We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Wyeth Keeps Positive Financial Outlook Despite Generic Competition, Lawsuits
Wyeth Keeps Positive Financial Outlook Despite Generic Competition, Lawsuits
March 1, 2007
Wyeth affirmed its strong financial forecast for 2007, although the company faces challenges from a prolonged FDA facility inspection, new generic competitors and litigation over its hormone-replacement therapies.